Sorrisos: OC(CCSC[C@@H]1[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]4[C@H](O)[C@@H](O)[C@H](O5)[C@@H](CSCCC(O)=O)O4)[C@@H](CSCCC(O)=O)O3)[C@@H](CSCCC(O)=O)O2)[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@@H]7[C@@H](CSCCC(O)=O)O[C@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H]5O[C@@H]9CSCCC(O)=O)O[C@@H]8CSCCC(OCC)=O)[C@H](O)[C@H]7O)O[C@@H]6CSCCC(O)=O)O1)=O
Inchi: InChI=1S/C72H112O50S8/c73-33(74)1-9-123-17-25-57-42(90)50(98)66(108-25)117-59-27(19-125-11-3-35(77)78)110-68(52(100)44(59)92)119-61-29(21-127-13-5-37(81)82)112-70(54(102)46(61)94)121-63-31(23-129(105)15-7-39(85)86)114-72(56(104)48(63)96)122-64-32(24-130(106)16-8-40(87)88)113-71(55(103)47(64)95)120-62-30(22-128-14-6-38(83)84)111-69(53(101)45(62)93)118-60-28(20-126-12-4-36(79)80)109-67(51(99)43(60)91)116-58-26(18-124-10-2-34(75)76)107-65(115-57)49(97)41(58)89/h25-32,41-72,89-104H,1-24H2,(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88)/t25-,26-,27-,28-,29-,30-,31-,32-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,129?,130?/m1/s1
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, Rajashree
From Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H
From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.